Lifecore Biomedical is dedicated to the development of technically advanced hyaluronan based products.
Lifecore Biomedical is dedicated to the development of technically advanced hyaluronan based products that offer long-term compatibility with the human body.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 25, 2022 | Post-IPO Equity | $5M | 1 |
Wynnefield Capital Advisors
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Wynnefield Capital Advisors
|
Yes | Post-IPO Equity |